SEATTLE, Nov. 02, 2023 (World NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a enterprise targeted on altering the possible for...
Announces
LOS ANGELES--(Business WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical organization, declared the poster presentation of a Phase I/II demo of...
Raising concentrate on ex vivo cell treatment platform centered on considerable preclinical and early translational medical knowledge suggesting capacity of...
This section is Partnership Content supplied The content in this section is supplied by GlobeNewswire for the purposes of distributing...
– Dependent on a novel human cytomegalovirus vector platform, VIR-1388 was created with the target of building a novel HIV...
PDS Biotechnology CompanyPRINCETON, N.J., Aug. 07, 2023 (World NEWSWIRE) -- PDS Biotechnology Company (Nasdaq: PDSB), a medical-phase immunotherapy firm producing...
.png?h=0d8e3a41&itok=arTs-Niz)
